Company Overview
| Stock Name | Wuxi XDC |
|---|---|
| Stock Code | 02268 |
| Company Full Name | To be extracted |
| Industry | 醫療保健 |
| Principal Activities | 公司是專注于全球ADC及更廣泛生物偶聯藥物市場的領先CRDMO,亦是一家致力于提供全面綜合服務的公司。 |
| Listing Date | 2023-11-17 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國江蘇省無錫市新吳區新輝環路11號 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | https://wuxixdc.com/ |
| Share Registrar | 香港中央證券登記有限公司 (Computershare Hong Kong Investor Services Limited) |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 20.60 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 63.8% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 1,102,800,400 |
Subscription Tiers
Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.
Pool A
| Lots Subscribed | Shares Subscribed | Subscription Amount (HKD) |
|---|---|---|
| 1 lots | 500 | HK$ 10,300 |
| 2 lots | 1,000 | HK$ 20,600 |
| 3 lots | 1,500 | HK$ 30,900 |
| 4 lots | 2,000 | HK$ 41,200 |
| 5 lots | 2,500 | HK$ 51,500 |
| 6 lots | 3,000 | HK$ 61,800 |
| 7 lots | 3,500 | HK$ 72,100 |
| 8 lots | 4,000 | HK$ 82,400 |
| 9 lots | 4,500 | HK$ 92,700 |
| 10 lots | 5,000 | HK$ 103,000 |
| 12 lots | 6,000 | HK$ 123,600 |
| 14 lots | 7,000 | HK$ 144,200 |
| 16 lots | 8,000 | HK$ 164,800 |
| 18 lots | 9,000 | HK$ 185,400 |
| 20 lots | 10,000 | HK$ 206,000 |
| 30 lots | 15,000 | HK$ 309,000 |
| 40 lots | 20,000 | HK$ 412,000 |
| 50 lots | 25,000 | HK$ 515,000 |
| 60 lots | 30,000 | HK$ 618,000 |
| 70 lots | 35,000 | HK$ 721,000 |
| 80 lots | 40,000 | HK$ 824,000 |
| 90 lots | 45,000 | HK$ 927,000 |
| 100 lots | 50,000 | HK$ 1,030,000 |
| 120 lots | 60,000 | HK$ 1,236,000 |
| 140 lots | 70,000 | HK$ 1,442,000 |
| 160 lots | 80,000 | HK$ 1,648,000 |
| 180 lots | 90,000 | HK$ 1,854,000 |
| 200 lots | 100,000 | HK$ 2,060,000 |
| 250 lots | 125,000 | HK$ 2,575,000 |
| 300 lots | 150,000 | HK$ 3,090,000 |
| 350 lots | 175,000 | HK$ 3,605,000 |
| 400 lots | 200,000 | HK$ 4,120,000 |
| 450 lots | 225,000 | HK$ 4,635,000 |
Pool B
| Lots Subscribed | Shares Subscribed | Subscription Amount (HKD) |
|---|---|---|
| 500 lots | 250,000 | HK$ 5,150,000 |
| 1,000 lots | 500,000 | HK$ 10,300,000 |
| 1,500 lots | 750,000 | HK$ 15,450,000 |
| 2,000 lots | 1,000,000 | HK$ 20,600,000 |
| 4,000 lots | 2,000,000 | HK$ 41,200,000 |
| 6,000 lots | 3,000,000 | HK$ 61,800,000 |
| 8,000 lots | 4,000,000 | HK$ 82,400,000 |
| 10,000 lots | 5,000,000 | HK$ 103,000,000 |
| 12,000 lots | 6,000,000 | HK$ 123,600,000 |
| 14,000 lots | 7,000,000 | HK$ 144,200,000 |
| 17,845 lots | 8,922,500 | HK$ 183,803,500 |
| 187,679 lots | 93,839,657 | HK$ 1,933,096,934 |
Stock Connect Inclusion Analysis
| Avg Daily HK Mkt Cap | --- |
|---|---|
| Analysis Result | Already included in Stock Connect (both) |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | Not disclosed |
| P/E Ratio | Not disclosed |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
| First Day Close | HK$ 2.52 |
|---|---|
| First Day Open | HK$ 2.3 |
| First Day Change | -2.30% |
| First Day Volume | 66988000.0 |
| First Day Turnover | 159746000.0 |
| Use of Proceeds | 1、約67%或2,333.8百萬港元將用于(i)在新加坡興建我們的設施及(ii)擴大我們在中國的服務實力及能力,以進一步擴大服務實力及能力;
2、約23%或801.2百萬港元將用于有選擇地尋求戰略聯盟、投資及收購機會,主要旨在擴大技術平臺及服務類型和能力;
3、約10%或348.3百萬港元用作營運資金及其他一般公司用途。 |
Underwriting Syndicate
Joint Sponsors (3)
Overall Coordinators (6)
Joint Bookrunners (6)
Joint Lead Managers (6)
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | Al-Rayyan Holding LLC | 351,981,900 HKD | — | 9.58% | — | 6 months | 2024-05-17 |
| 2 | General Atlantic Singapore SPV 64 Pte. Ltd. | 391,091,000 HKD | — | 10.64% | — | 6 months | 2024-05-17 |
| 3 | HongShan Funds | 234,654,600 HKD | — | 6.38% | — | 6 months | 2024-05-17 |
| 4 | Invesco Advisers, Inc. | 782,182,000 HKD | — | 21.28% | — | 6 months | 2024-05-17 |
| 5 | Lake Bleu Prime Healthcare Master Fund Limited | 78,218,200 HKD | — | 2.13% | — | 6 months | 2024-05-17 |
| 6 | Novo Holdings A/S | 195,545,500 HKD | — | 5.32% | — | 6 months | 2024-05-17 |
| 7 | UBS Asset Management (Singapore) Ltd. | 312,872,800 HKD | — | 8.51% | — | 6 months | 2024-05-17 |
Directors & Management
| Position | Chinese name | English Name |
|---|---|---|
| Chairman | 陳智勝 | — |
| Company Secretary | 席曉捷 | — |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 藥明生物技術有限公司(50.91%);合全藥業香港投資有限公司(33.94%) |
|---|




